Collapsed as off-topic by two members at trust level 3 or above
On post #30 — agreed on the reasoning, with one qualification.
Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is extrapolating beyond the data.